About the organization:
The Pediatric Endocrine Society (PES) is the leading professional society for this specialty in the United States. The mission of PES is to advance and promote the endocrine health and well-being of children and adolescents. The PES has over 1200 members representing the multiple disciplines of Pediatric Endocrinology.
The PES Transgender and Gender Non-Conforming Youth Special Interest Group is dedicated to providing safe, comprehensive and evidence based medical care to transgender and gender nonconforming youth.
Statements:
-
Statement on Gender Affirmative Approach to Care from the Pediatric Endocrine Society Special Interest Group on Transgender Health
Ximena Lopez, Maja Marinkovic, Toni Eimicke, Stephen M. Rosenthal & Jerrold S. Olshan, “Statement on gender-affirmative approach to care from the pediatric endocrine society special interest group on transgender health.” Current opinion in pediatrics vol. 29,4 (2017): 475-480. doi:10.1097/MOP.0000000000000516
"[T]ransgender youth have optimal outcomes when affirmed in their gender identity, through support by their families and their environment, as well as appropriate mental health and medical care. For this reason, the Pediatric Endocrine Society Special Interest Group on Transgender Health joins other academic societies involved in the care of children and adolescents in supporting policies that promote a safe and accepting environment for gender nonconforming/transgender youth, as well as adequate mental health and medical care."
Date: May 27, 2017
-
PES Statement Promoting Safety of Transgender Youth
"The Pediatric Endocrine Society (PES), the leading professional society for this specialty in the United States, strongly opposes the guidance issued on February 22, 2017, by the Departments of Justice and Education, which eliminates protection of the rights of transgender youth."
Date: March 2017
-
PES Fact Sheet: Masculinizing Treatment for Transgender Males
Date: 2018
-
PES Fact Sheet: Feminizing Treatment for Transgender Females
Date: 2018
